Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, August 12, 2024
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
Les Sulewski Maintained (AMRX) at Strong Buy with Increased Target to $10 on, Aug 12th, 2024
Les Sulewski of Truist Securities, Maintained "Amneal Pharmaceuticals, Inc." (AMRX) at Strong Buy with Increased Target from $9 to $10 on, Aug 12th, 2024.
Les has made no other calls on AMRX in the last 4 months.
There is 1 other peer that has a rating on AMRX. Out of the 1 peers that are also analyzing AMRX, 0 agree with Les's Rating of Hold.
This is the rating of the analyst that currently disagrees with Les
- Nathan Rich of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $8 on, Monday, May 6th, 2024
